Cosciens Biopharma’s Management Hits the Pause Button: A Cease Trade Order Explained
COSCIENS Biopharma: A Major Development in Canadian Securities Toronto, Ontario, April 1, 2025 – In a significant turn of events, COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI), a leading life science company specializing in the development and commercialization of cosmeceutical, nutraceutical, and pharmaceutical products, has announced that its application for a management cease trade order…